Drugs that contain Montelukast Sodium
1. Singulair patents expiration
SINGULAIR's oppositions filed in EPO
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
|
US5565473 (Pediatric) | ORGANON | Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists |
Aug, 2012
(11 years ago) | |
| US8007830 | ORGANON | Granule formation |
Oct, 2022
(1 year, 6 months ago) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Patient Population(NPP) | Mar 26, 2015 |
Market Authorisation Date: 20 February, 1998
Treatment: NA
Dosage: TABLET;ORAL; TABLET, CHEWABLE;ORAL; GRANULE;ORAL
How can I launch a generic of SINGULAIR before it's drug patent expiration?
More Information on Dosage
SINGULAIR family patents
